Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib. Bortezomib is a reversible and selective inhibitor of the proteasome with a Ki of 0.6 nM for 20S proteasome.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
2 mg | In stock | $ 148.00 | |
5 mg | In stock | $ 287.00 | |
10 mg | In stock | $ 497.00 | |
25 mg | In stock | $ 796.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,450.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 293.00 |
Description | (1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib. Bortezomib is a reversible and selective inhibitor of the proteasome with a Ki of 0.6 nM for 20S proteasome. |
Targets&IC50 | 20S proteasome(ki):ki:0.6 nM |
In vitro | Bortezomib disrupts the cell cycle, induces apoptosis, inhibits NF-κB, and possesses anti-cancer capacity[1]. |
Synonyms | Bortezomib |
Molecular Weight | 384.24 |
Formula | C19H25BN4O4 |
CAS No. | 1132709-14-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (104.1 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(1S,2S)-Bortezomib 1132709-14-8 Proteases/Proteasome Ubiquitination Proteasome Bortezomib inhibitor inhibit